Skip to main content

Advertisement

Log in

Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Antiseptic coating of intravascular catheters may be an effective means of decreasing catheter-related colonization and subsequent infection. The purpose of this study was to assess the efficacy of chlorhexidine and silver sulfadiazine (CH-SS)-impregnated central venous catheters (CVCs) to prevent catheter-related colonization and infection in patients with hematological malignancies who were subjected to intensive chemotherapy and suffered from severe and sustained neutropenia. Proven CVC-related bloodstream infection (BSI) was defined as the isolation of the same species from peripheral blood culture and CVC tip (Maki technique). This randomized, prospective clinical trial was carried out in 106 patients and compared catheter-related colonization and BSI using a CH-SS-impregnated CVC (n=51) to a control arm using a standard uncoated triple-lumen CVC (n=55). Patients were treated for acute leukemia (n=89), non-Hodgkin’s lymphoma (n=10), and multiple myeloma (n=7). Study groups were balanced regarding to age, sex, underlying diseases, insertion site, and duration of neutropenia. The CVCs were in situ a mean of 14.3±8.2 days (mean±SD) in the study group versus 16.6±9.7 days in the control arm. Catheter-related colonization was observed less frequently in the study group (five vs nine patients; p=0.035). CVC-related BSI were significantly less frequent in the study group (one vs eight patients; p=0.02). In summary, in patients with severe neutropenia, CH-SS-impregnated CVCs yield a significant antibacterial effect resulting in a significantly lower rate of catheter-related colonization as well as CVC-related BSI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pittet D, Tamara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598–1601

    CAS  PubMed  Google Scholar 

  2. Dettenkofer M, Ebner W, Bertz H, Babikir R, Finke J, Frank U, Ruden H, Daschner FD (2003) Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 31:795–801

    Article  CAS  PubMed  Google Scholar 

  3. Karthaus M, Suedhoff T, Reichardt P, Bowden C, for the Fragmin-Study Group (2002) Frequency of central venous catheter (CVC)-related infections in cancer patients (CP) treated on a double-blind Phase III trial of dalteparin versus placebo for the prevention of catheter-related complications (CRC). Proceedings of the 42nd ICAAC, San Diego, 27–30 September 2002, p K667

  4. Li C, Zhang X, Whitbourne R (1999) In vitro antimicrobial activity of a new antiseptic central venous catheter. J Biomater Appl 13:206–223

    CAS  PubMed  Google Scholar 

  5. Moss HA, Tebbs SE, Faroqui MH, Herbst T, Isaac JL, Brown J, Elliott TS (2000) A central venous catheter coated with benzalkonium chloride for the prevention of catheter-related microbial colonization. Eur J Anaesthesiol 17:680–687

    Article  CAS  PubMed  Google Scholar 

  6. Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggemann A, Napolitano LM, Edwards LP, O’Connell FM, Puyana JC, Doern GV (1998) Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 158:81–87

    Article  CAS  PubMed  Google Scholar 

  7. Logghe C, Van Ossel C, D’Hoore W, Ezzedine H, Wauters G, Haxhe JJ (1997) Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukemic patients: a randomized controlled trial. J Hosp Infect 37:145–156

    Article  CAS  PubMed  Google Scholar 

  8. Tennenberg S, Lieser M, McCurdy B, Boomer G, Howington E, Newman C, Wolf I (1997) A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 132:1348–1351

    CAS  PubMed  Google Scholar 

  9. Schmitt SK, Knapp C, Hall GS, Longworth DL, McMahon JT, Washington JA (1996) Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. J Clin Microbiol 34:508–511

    CAS  PubMed  Google Scholar 

  10. George SJ, Vuddamalay P, Boscoe MJ (1997) Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol 14:428–431

    Article  CAS  PubMed  Google Scholar 

  11. Hannan M, Juste RN, Umasanker S, Glendenning A, Nightingale C, Azadian B, Soni N (1999) Antiseptic-bonded central venous catheters and bacterial colonisation. Anaesthesia 54:868–872

    Article  CAS  PubMed  Google Scholar 

  12. Boswald M, Lugauer S, Regenfus A, Braun GG, Martus P, Geis C, Scharf J, Bechert T, Greil J, Guggenbichler JP (1999) Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection 27:S56–S60

    PubMed  Google Scholar 

  13. Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296:1305–1309

    CAS  PubMed  Google Scholar 

  14. Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehn TE, Armstrong D (1993) Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168–1174

    CAS  PubMed  Google Scholar 

  15. Raad I (1998) Intravascular-catheter-related infections. Lancet 351:893–898

    Article  CAS  PubMed  Google Scholar 

  16. Seifert H, Cornely O, Seggewiss K, Decker M, Stefanik D, Wisplinghoff H, Fatkenheuer G (2003) Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J Clin Microbiol 41:118–123

    Article  PubMed  Google Scholar 

  17. Buchheidt D, Bohme A, Cornely OA, Fatkenheuer G, Fuhr HG, Heussel G, Junghanss C, Karthaus M, Kellner O, Kern WV, Schiel X, Sezer O, Sudhoff T, Szelenyi H, Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (2003) Central venous catheter (CVC)-related infections in neutropenic patients—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82 [Suppl 2]:S149–S157

    Article  PubMed  Google Scholar 

  18. Broadwater JR, Henderson MA, Bell JL, Edwards MJ, Smith GJ, McCready DR, Swanson RS, Hardy ME, Shenk RR, Lawson M (1990) Outpatient percutaneous central venous access in cancer patients. Am J Surg 160:676–680

    CAS  PubMed  Google Scholar 

  19. Raad II, Hachem RY, Abi-Said D, Rolston KV, Whimbey E, Buzaid AC, Legha S (1998) A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2. Cancer 82:403–411

    Article  CAS  PubMed  Google Scholar 

  20. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD (1999) Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281:261–267

    Article  CAS  PubMed  Google Scholar 

  21. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G (1999) A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 340:1–8

    Article  CAS  PubMed  Google Scholar 

  22. Darouiche RO (1999) Prevention of vascular catheter-related infections. Neth J Med 55:92–99

    Article  CAS  PubMed  Google Scholar 

  23. Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B, Flynn L, Hayes S, Strong S, Cruz J, Bowton DL, Hulgan T, Haponik EF (2000) Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 132:641–648

    CAS  PubMed  Google Scholar 

  24. Alonso-Echanove J, Edwards JR, Richards MJ, Brennan P, Venezia RA, Keen J, Ashline V, Kirkland K, Chou E, Hupert M, Veeder AV, Speas J, Kaye J, Sharma K, Martin A, Moroz VD, Gaynes RP (2003) Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 24:916–925

    PubMed  Google Scholar 

  25. Carratala J, Niubo J, Fernandez-Sevilla A, Juve E, Castellsague X, Berlanga J, Linares J, Gudiol F (1999) Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 43:2200–2204

    CAS  PubMed  Google Scholar 

  26. Leon C, Alvarez-Lerma F, Ruiz-Santana S, Gonzalez V, de la Torre MV, Sierra R, Leon M, Rodrigo JJ (2003) Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study. Crit Care Med 31:1318–1324

    Article  PubMed  Google Scholar 

  27. Carrasco MN, Bueno A, de las Cuevas C, Jimenez S, Salinas I, Sartorius A, Recio T, Generelo M, Ruiz-Ocana F (2004) Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Med 30:633–638

    Article  CAS  PubMed  Google Scholar 

  28. Safdar N, Maki DG (2004) The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 30:62–67

    Article  PubMed  Google Scholar 

  29. Zitella L (2003) Central venous catheter site care for blood and marrow transplant recipients. Clin J Oncol Nurs 7:289–298

    PubMed  Google Scholar 

Download references

Acknowledgments

We are indebted to the physicians and nurses of the Department of Hematology and Oncology for their support throughout the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Karthaus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jaeger, K., Zenz, S., Jüttner, B. et al. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Ann Hematol 84, 258–262 (2005). https://doi.org/10.1007/s00277-004-0972-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-004-0972-6

Keywords

Navigation